Skip to main content Back to Top
Advertisement

5/20/2019

Dicyclomine Injection

Products Affected - Description

    • Dicyclomine hydrochloride intramuscular solution for injection, Hikma, 10 mg/mL, 2 mL single dose vial, 10 count, NDC 00641-6173-10

Reason for the Shortage

    • Allergan has Bentyl injection available.
    • American Regent did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage.
    • Nexus has dicyclomine injection for intramuscular use available.

Available Products

    • Bentyl intramuscular solution for injection, Allergan, 10 mg/mL, 2 mL ampule, 5 count, NDC 58914-0080-52
    • Dicyclomine hydrochloride intramuscular solution for injection, American Regent, 10 mg/mL, 2 mL single dose vial, 5 count, NDC 00517-1980-05
    • Dicyclomine hydrochloride intramuscular solution for injection, Nexus Pharmaceuticals, 10 mg/mL, 2 mL single dose vial, 5 count, NDC 14789-0010-02

Estimated Resupply Dates

    • Hikma has dicyclomine 10 mg/mL 2 mL vials on back order and the company cannot estimate a release date.

Updated

Updated May 20, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 16, 2019 by Stephen Andrews, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins